Abstract
The aim of this study is to assess the prevalence and predictors of depressive symptoms in women with polycystic ovary syndrome (PCOS). In a cross-sectional study of 114 women seeking consultation for symptoms of PCOS (menstrual irregularity, hirsutism, and/or acne), personal and family history of depression (HD and FHD respectively) were enquired. Vitamin D status (n = 104) and manifest depressive symptoms assessed by personal health questionnaire (PHQ) (MD) were evaluated in a subset (85). Relationships between HD and MD with PCOS symptoms, FHD, and vitamin D status were assessed using adjusted analyses. Thirty-five percent acknowledged a HD; MD (PHQ > 4) was apparent in 43 %. HD was associated with hirsutism (OR 2.4, 95 % CI 1.01–5.9), disturbed sleep (OR 3.0, 95 % CI 1.3–6.9), and with FHD (OR 4.8, 95 % CI 1.7–13.5). Disturbed sleep (OR 2.4, 95 % CI 1.01–5.7) and FHD (OR 3.8, 95 % CI 1.3–11.2) were independent predictors of HD adjusting for race and BMI. An inverse correlation was noted between serum 25 OH vitamin D (25OHD) levels and PHQ score, but only in those with vitamin D deficiency (25OHD ≤ 30 ng/ml, n = 57, r =−0.32, p = 0.015). 25OHD < 20 ng/ml (OR 3.5, 95 % CI 1.1–11.8) and HD (OR 12.8, 95 % CI 3.6–45.2) predicted scoring in the highest PHQ tertile after adjusting for hirsutism, BMI, and race. In women with PCOS, disturbed nocturnal sleep and FDH predicted personal HD, whereas HD and vitamin D deficiency related to the severity of MD symptoms.
Similar content being viewed by others
References
Azziz R, Woods KS, Reyna R, Key TJ et al (2004) The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89(6):2745–2749
Catherine Marin DU, Woods KS, Alfred A, Bartolucci, Ricardo A (2006) Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 91:1345–1350
Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L (2005) A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 152(5):986–992
Dokras A (2012) Mood and anxiety disorders in women with PCOS. Steroids 77(4):338–341
Drosdzol A, Skrzypulec V, Plinta R (2010) Quality of life, mental health and self-esteem in hirsute adolescent females. J Psychosom Obstet Gynaecol 31(3):168–175
Hoang MT, Defina LF, Willis BL, Leonard DS, Weiner MF, Brown ES (2011) Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 86(11):1050–1055
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930
Hosmer DW, Lemeshow S (2000) Applied Logistic Regression. Wiley, New York
Jaussent I, Bouyer J, Ancelin ML, Akbaraly T, Pérès K, Ritchie K, Besset A, Dauvilliers Y (2011) Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep 34(8):1103–1110
Jaworska N, Thompson A, Shah D, Fisher D, Ilivitsky V, Knott V (2012) Acute tryptophan depletion effects on the vertex and late positive potentials to emotional faces in individuals with a family history of depression. Neuropsychobiology 65(1):28–40
Kao CC, Huang CJ, Wang MY, Tsai PS (2008) Insomnia: prevalence and its impact on excessive daytime sleepiness and psychological well-being in the adult Taiwanese population. Qual Life Res 17(8):1073–1080
Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2009) Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 92(3):1053–1058
Kroenke K, Spitzer RL, Williams JB, Löwe B (2010) The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 32(4):345–359, Review
Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K et al (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262–270
Norman A (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. In: The American Journal of Clinical Nutrition, 491S–9S
Pal L, Berry A, Coraluzzi L, Kustan E, Danton C, Shaw J et al (2012) Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 28(12):965–968
Parish J (2009) Sleep-related problems in common medical conditions. Chest 135(2):563–572
Rashidi B, Haghollahi F, Shariat M, Zayerii F (2009) The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 48(2):142–147
Rosen CJ, Gallagher JC (2011) The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 14(2):79–84, Review
Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R (2011) An update on the presence of psychiatric comorbidities in acne patients, Part 2: depression, anxiety, and suicide. Cutis 88(2):92–97
Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G, Tuncel E, Erturk E, Imamoglu S (2010) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33(4):234–238
Teede H, Deeks A, Moran L (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 8:41
Wehr E, Schweighofer N, Giuliani A, et al. (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. In: European Journal of Endocrinology, 575–582
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Naqvi, S.H., Moore, A., Bevilacqua, K. et al. Predictors of depression in women with polycystic ovary syndrome. Arch Womens Ment Health 18, 95–101 (2015). https://doi.org/10.1007/s00737-014-0458-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-014-0458-z